Search

everythinglearnresearchcommunity

for

Search:↓

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Phytoconstituents from Cyperus Rotundus may help treat hirsutism by interacting with the 5 α reductase enzyme.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

A neem-based herbal treatment worked better than ivermectin for sarcoptic mange in camels, improving their recovery and overall health.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Tick bites can cause temporary hair loss similar to alopecia areata in some people.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.